Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Middleton

Showing results (21-30 of 522) with videos related to

Pageof 53
Sort By:
Expert Opinion on Investigational Drugs|October 10, 2007
The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitorsOmar Khan, Mark R Middleton
American Journal of Clinical Dermatology|April 1, 2022
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic MelanomaFrancesca Aroldi, Mark R Middleton
Cancer Treatment Reviews|November 22, 2005
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancerSrinivasan Madhusudan, Mark R Middleton
The Journal of Pharmacy and Pharmacology|December 1, 1974
Proceedings: The effect of chloroquine on the growth and viability of Escherichia coliK R Middleton, D Wiseman
The Journal of Pharmacy and Pharmacology|December 1, 1979
The effect of chloroquine on macromolecule synthesis and oxygen uptake in Escherichia coli [proceedings]K R Middleton, D Wiseman
Biophysical Journal|October 7, 2010
Effects of curvature and composition on α-synuclein binding to lipid vesiclesElizabeth R Middleton, Elizabeth Rhoades
British Journal of Cancer|May 5, 2001
Adjuvant interferon in melanoma - a resurrection?M R Middleton, N Thatcher
Prosthetics and Orthotics International|December 1, 1984
Cold injury amputees--a psychosocial problem?J Hunter, F R Middleton
Current Opinion in Pharmacology|June 17, 2006
Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapyAmi Sabharwal, Mark R Middleton
Critical Care Nurse|June 1, 1997
Direct arterial vs oscillometric monitoring of blood pressure: stop comparing and pick one (a decision-making algorithm)M E Bridges, R Middleton
Pageof 53

Showing results (21-30 of 522) with videos related to

Sort By:
Pageof 53
Expert Opinion on Investigational Drugs|October 10, 2007
The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitorsOmar Khan, Mark R Middleton
American Journal of Clinical Dermatology|April 1, 2022
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic MelanomaFrancesca Aroldi, Mark R Middleton
Cancer Treatment Reviews|November 22, 2005
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancerSrinivasan Madhusudan, Mark R Middleton
The Journal of Pharmacy and Pharmacology|December 1, 1974
Proceedings: The effect of chloroquine on the growth and viability of Escherichia coliK R Middleton, D Wiseman
The Journal of Pharmacy and Pharmacology|December 1, 1979
The effect of chloroquine on macromolecule synthesis and oxygen uptake in Escherichia coli [proceedings]K R Middleton, D Wiseman
Biophysical Journal|October 7, 2010
Effects of curvature and composition on α-synuclein binding to lipid vesiclesElizabeth R Middleton, Elizabeth Rhoades
British Journal of Cancer|May 5, 2001
Adjuvant interferon in melanoma - a resurrection?M R Middleton, N Thatcher
Prosthetics and Orthotics International|December 1, 1984
Cold injury amputees--a psychosocial problem?J Hunter, F R Middleton
Current Opinion in Pharmacology|June 17, 2006
Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapyAmi Sabharwal, Mark R Middleton
Critical Care Nurse|June 1, 1997
Direct arterial vs oscillometric monitoring of blood pressure: stop comparing and pick one (a decision-making algorithm)M E Bridges, R Middleton
Pageof 53